Bengaluru: The state cabinet Thursday approved the Startup Policy 2025–2030, a five-year plan with an outlay of Rs 518 crore ...

Conroe-based bio-tech company VGXI Inc. has defaulted on its tax abatement agreement with Montgomery County and will pay more ...

Colossal Bioscience has cloned former NFL star Tom Brady's dog, drawing the ire from some who are calling for a moratorium on ...

Vgenomics offers RgenX, an AI-powered cloud platform that diagnoses rare genetic diseases and accelerates drug discovery by ...

This week, Brady casually dropped the bombshell that his new dog, Junie, is a clone of the family’s former pit mix, Lua, who ...

Today, Gubra releases its results for the third quarter of 2025. In September, Gubra welcomed Markus Rohrwild as our new CEO. The third quarter has been characterized by expansion of our R&D ...

A team of scientists is employing a technique used to detect invasive species to search for troops lost at sea.

In January 2019, Locus entered a collaboration with Janssen Pharmaceuticals, one of Johnson & Johnson's companies, to develop ...

In interviews with The Daily Cardinal, tech leaders Jim Thompson, Mike Trigg and Allen Dines reflect on how AI has shaped ...

By signing of a memorandum of understanding (MoU) with Illumina, a global leader in sequencing technology, the Department of Science, Technology and Innovation (DSTI) and the South African Medical ...

Seattle's Parse Biosciences is teed up for an acquisition by Qiagen, a Netherlands-based holding company, in a $225 million ...

With an AI-led platform for drug discovery and a growing global client base, Medvolt AI is emerging as one of India’s most ...